Overview of Sigma Healthcare's voluntary suspension request

Sigma Healthcare Limited (ASX:SIG) has requested a voluntary suspension of its ordinary shares under Listing Rule 17.2. The suspension is in relation to a potential material transaction for which discussions are ongoing, and Sigma is unable to provide an announcement at this time. The company anticipates the suspension to continue until the announcement of the material transaction or the commencement of trading on 11 December 2023.

Executive commentary on the voluntary suspension request

Sigma Healthcare Limited has requested a voluntary suspension of its ordinary shares to ensure that the market is not trading on an uninformed basis while discussions regarding a potential material transaction are ongoing. The company is committed to providing the market with necessary information at the earliest opportunity and believes that the voluntary suspension is in the best interest of informed trading.

Summary of Sigma Healthcare's voluntary suspension and outlook

Sigma Healthcare Limited (ASX:SIG) has taken the step to request a voluntary suspension of its ordinary shares in light of ongoing discussions related to a potential material transaction. The company aims to provide the market with timely and accurate information once the discussions are concluded. The voluntary suspension is expected to remain in place until the announcement of the material transaction or the commencement of trading on 11 December 2023. Sigma Healthcare is focused on ensuring that the market is well-informed and anticipates providing further updates as soon as possible.